Breaking News
January 23, 2019 - Medical expert advises people with epilepsy not to stockpile medicines
January 23, 2019 - Bedfont to exhibit NObreath FeNO monitor at Arab Health 2019
January 23, 2019 - Nicotinamide riboside supplementation confers significant physiological benefits to mothers and offspring
January 23, 2019 - Increasing temperatures may help preserve crop nutrition
January 23, 2019 - Many Oncologists in the Dark About LGBTQ Health Needs
January 23, 2019 - Epigenetic change causes fruit fly babies to inherit diet-induced heart disease
January 23, 2019 - Erasing memories could reduce relapse rates among drug addicts
January 23, 2019 - African Americans who smoke cigarettes are more likely to develop peripheral artery disease
January 23, 2019 - Unique data combination helps FinnGen researchers to fund links between genetic factors and health
January 23, 2019 - Parents’ mental health problems associated with reactive attachment disorder in children
January 23, 2019 - Graphene Flagship project studies impact of graphene and related materials on our health
January 23, 2019 - The connection between the Pope and contraceptive pills
January 23, 2019 - Prior dengue infection could protect children from symptomatic Zika
January 23, 2019 - VISTA checkpoint implicated in pancreatic cancer immunotherapy resistance
January 23, 2019 - The Tiny Camera That Could Revolutionize Cardiovascular Surgery
January 23, 2019 - Peptide isolated from soil fungi has antitumor and antibacterial properties
January 23, 2019 - TGen identifies polio-like virus as potential cause of Acute Flaccid Myelitis outbreak
January 23, 2019 - Migrants and refugees do not bring disease and are at greater health risk themselves says WHO
January 23, 2019 - Examing the effects of menopause in workplace
January 23, 2019 - Enemy number 1 – Air pollution and climate change top of WHO agenda
January 23, 2019 - Two Positive Phase III studies of Tafenoquine for the Radical Cure of Plasmodium vivax Malaria Published in The New England Journal of Medicine
January 23, 2019 - World Trade Center responders at increased risk for head and neck cancers
January 23, 2019 - Low-sugar diet leads to significant improvement in nonalcoholic fatty liver disease in boys
January 23, 2019 - Chaos in bodily regulation can optimize our immune system, finds study
January 23, 2019 - Short, text-based exercises can increase happiness for adults recovering from substance use disorders
January 23, 2019 - Body size may have greater influence on women’s lifespan than men
January 23, 2019 - Groundbreaking tool helps visualize neuronal activity with near-infrared light
January 23, 2019 - Prior dengue immunity in children may be protective against symptomatic Zika
January 23, 2019 - Holocaust survivors with PTSD and their offspring exhibit more unhealthy behavior patterns
January 23, 2019 - Scientists discover new genetic mutations causing inherited deaf-blindness
January 23, 2019 - UC team designs new naloxone-dispensing smart device
January 23, 2019 - Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium and Hydrochlorothiazide Tablets, USP
January 23, 2019 - Brain activity shows development of visual sensitivity in autism
January 23, 2019 - Two hour gap between dinner and sleep is overrated says Japanese research
January 23, 2019 - Fear and embarrassment are causing smear test numbers to plummet
January 23, 2019 - Protein-secreting device implanted in epileptic rats reduces seizures, improves cognition
January 23, 2019 - Reintroduction project recovers current wild population of green turtle in Cayman Islands
January 23, 2019 - Cancer survivors face greater financial burden related to medical bills
January 23, 2019 - PSA screening reduces prostate cancer deaths by 30%
January 23, 2019 - LSTM receives grant to help improve health of people living in informal settlements
January 23, 2019 - Hemochromatosis Mutation Linked to Other Morbidity
January 23, 2019 - Why early diagnosis of autism should lead to early intervention
January 23, 2019 - Aspirin May Lower Stroke Risk in Women with History of Preeclampsia
January 23, 2019 - Exposure to certain chemicals may be linked to decrease in blood pressure during pregnancy
January 23, 2019 - Bowel cancer on the rise among younger Australians
January 23, 2019 - Scientists have reversed memory loss in a mouse model of Alzheimer’s
January 23, 2019 - Defective molecular master switch could lead to age-related macular degeneration
January 23, 2019 - Researchers identify how concussions may contribute to seizures
January 23, 2019 - Short interval between last meal of the day and bedtime may not affect blood glucose levels
January 23, 2019 - Still Too Many Highway Deaths Tied to Speeding
January 23, 2019 - Prenatal valproate exposure linked to increased ADHD risk
January 23, 2019 - Compound identified that may help treat heart failure
January 23, 2019 - Undiagnosed Asthma in Urban Adolescents May Be Common
January 23, 2019 - Study describes metabolism of intestinal microbiota in babies for the first time
January 22, 2019 - Study links concussions to development of epilepsy
January 22, 2019 - Specialist-led hospital bereavement service may help restrain legal action after difficult deaths
January 22, 2019 - Genetic study reveals possible new routes to treating osteoarthritis
January 22, 2019 - Blood test may detect early signs of lung-transplant rejection
January 22, 2019 - Blood marker could aid in early prediction of Alzheimer’s progression
January 22, 2019 - Orthodontic treatment does not guarantee future dental health
January 22, 2019 - Rutgers researchers discover cause of bone loss in people with joint replacements
January 22, 2019 - Diversity among rural Africans extends to their gut microbiomes
January 22, 2019 - Newly developed biological system lets cells to create self-curving cornea
January 22, 2019 - VTv Therapeutics Announces Publication of Comprehensive Data in Science Translational Medicine Detailing the Discovery and Clinical Development of TTP399, including Results of Phase 2 AGATA Study
January 22, 2019 - about one in three adults with prediabetes has arthritis
January 22, 2019 - A look at how data is democratizing health care
January 22, 2019 - Alcohol-Linked Disease Overtakes Hep C As Top Reason For Liver Transplant
January 22, 2019 - Researchers identify new genes linked with age-related macular degeneration
January 22, 2019 - MPFI researchers identify synaptic logic for connections between two brain hemispheres
January 22, 2019 - New approach to reduce toxic protein production in ALS
January 22, 2019 - New study extends our knowledge of the link between miRNAs and cancer
January 22, 2019 - Asthma, eczema are not barriers to active lifestyle in teenagers
January 22, 2019 - Genetic changes may predict likelihood of relapse in breast cancer patients
January 22, 2019 - Antiepileptic drug use by people with Alzheimer’s disease linked to accumulation of hospital days
January 22, 2019 - IUPUI researcher receives $2.85 million grant to find ways to improve bone strength
January 22, 2019 - Precision medicine can help keep astronauts healthy during deep space missions
January 22, 2019 - Detecting signs of neurodegeneration earlier and more accurately
January 22, 2019 - Mouse studies challenge ‘inhibition’ theory of autism
January 22, 2019 - SSB launches BIOSTAT RM TX single-use bioreactor for producing consistent quality cellular products
January 22, 2019 - Experimental drug can positively modify key characteristic behavior in FXS patients
Young-Onset Breast Cancer Survival Unaffected by BRCA Status

Young-Onset Breast Cancer Survival Unaffected by BRCA Status

image_pdfDownload PDFimage_print

Action Points

  • Note that this observational study of young (less than age 40) women with breast cancer demonstrated similar survival after diagnosis regardless of BRCA mutation status.
  • Interestingly, prompt bilateral mastectomy did not confer a survival advantage among the BRCA carriers.

BRCA-positive breast cancer is associated with survival rates similar to those for BRCA-negative cancer in young women after treatment, according to a large, ongoing, prospective study in the U.K.

BRCA carriers with triple-negative breast cancer, however, may have a survival advantage over those without the mutation in the first few years after diagnosis, reported Diana M. Eccles, MD, of the University of Southampton School of Medicine, and colleagues in The Lancet Oncology.

“Women diagnosed with early breast cancer who carry a BRCA mutation are often offered double mastectomies soon after their diagnosis or chemotherapy treatment; however, our findings suggest that this surgery does not have to be immediately undertaken along with the other treatment,” Eccles said in a statement.

“In the longer term, risk-reducing surgery should be discussed as an option for BRCA1 mutation carriers in particular, to minimize their future risk of developing a new breast or ovarian cancer,” she added. “Decisions about timing of additional surgery to reduce future cancer risks should take into account patient prognosis after their first cancer, and their personal preferences.”

While only 5% of breast cancers are diagnosed in women under age 40, a significant proportion of deaths from breast cancer occur in this age group, including a high number who carry a pathogenic BRCA1 or BRCA2 mutation. Second primary breast cancers also are more frequent in high-risk gene carriers.

For the study, called POSH (Prospective Outcomes in Sporadic versus Hereditary), the researchers recruited female patients from 127 hospitals in the U.K. who were ages 18 to 40 when first diagnosed with invasive breast cancer, excluding those with a previous invasive malignancy. Recruitment stopped in 2008, and long-term follow-up is continuing.

All patients received treatment according to local protocols. Nearly 90% underwent chemotherapy. Half had breast-conserving surgery, and half had a mastectomy. The most common chemotherapy regimen was anthracycline, with or without taxanes.

The researchers examined detailed clinical follow-up information, including date and site of disease recurrence, at 6 months and 12 months, and then annually.

The primary outcome was overall survival — defined as the time from first diagnosis to death from any cause — comparing all BRCA1 or BRCA2 mutation carriers (BRCA-positive) with non-carriers (BRCA-negative). The secondary outcome was distant disease-free survival, defined as time from initial diagnosis to first distant disease.

Of 2,733 patients in the POSH analysis, 338 (12%) carried either a BRCA1 or BRCA2 mutation. Of the total sample, 558 women (20%) had triple-negative breast cancer. BRCA mutations were identified in 136 (24%) of patients with triple-negative breast cancer, and 123 of these women (90%) had a BRCA1 mutation.

The median follow-up was 8.2 years. In that period, 678 women died — 651 due to breast cancer.

The survival rates for both BRCA carriers and non-carriers were similar: after 2 years, the survival rates were 97% for carriers and 96.6% for non-carriers. After 5 years, the rates were 83.8% and 85%, and after 10 years, 73.4% versus 70.1%. Distant disease-free survival rates also were similar in both groups.

These results did not vary between unadjusted or adjusted analyses, including adjustments for ethnicity and body mass index.

Immediate bilateral mastectomy also was not associated with improved survival.

A subgroup analysis of 558 women with triple-negative breast cancer suggested that BRCA carriers initially may have better overall survival than women not carrying the mutation — 95% versus 91% at 2 years — but survival was similar at 5 or 10 years, for unclear reasons. This early survival advantage also has been seen in ovarian cancer patients who have the BRCA mutation, the authors noted.

Asked for her perspective, Virginia Kaklamani, MD, DSc, of the University of Texas Health Science Center at San Antonio, who was not involved in the study, said: “This is the largest prospective study looking at outcomes in BRCA-related breast cancer. Prior studies have shown some conflicting results regarding the breast cancer-related prognosis, but most have pointed to the fact that breast cancer outcomes are similar between BRCA carriers and non-carriers. This study confirms these findings.”

In an editorial accompanying the study, Peter Fasching, MD, of the Friedrich Alexander University Erlangen-Nuremberg in Germany, observed that while 338 patients in the POSH cohort had a BRCA1 or BRCA2 mutation, only 54% of the mutation carriers — 182 women — had been identified through routine healthcare.

“In most national and international guidelines, testing criteria include patients with breast cancer ages less than 35 or 40,” he wrote. “The fact that in the POSH study there were 155 young women diagnosed with breast cancer who did not know their mutation status raises the question of whether and when testing criteria for certain groups of patients can be allowed for lower mutation probabilities.”

Limitations of the study, the authors noted, included the fact that since it was restricted to women 40 or younger, the observations in young patients might not translate to women who were older when diagnosed. In addition, because triple-negative breast cancer was not well understood when the study was designed, it was therefore not powered for this as a primary outcome. Furthermore, breast cancer treatment recommendations in the U.K. also changed over the course of recruitment, which may have affected the survival rates.

The study was funded by Cancer Research UK, the UK National Cancer Research Network, the Wessex Cancer Trust, Breast Cancer Now, and the PPP Healthcare Medical Trust Grant.

The authors reported financial relationships with Roche, GSK, Pfizer, AstraZeneca, and Pierre Fabre.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2018-01-13T10:00:00-0500

Tagged with:

About author

Related Articles